Navigation Links
Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target

er in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 23,600 employees in 79 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit http://novonordisk.com.

References:

1. Seino Y, Kaku K, Nishijima K, et al. "Once Daily Dosing of the long acting GLP-1 analogue Liraglutide Significantly Improves Glycaemic Control by Reducing both Fasting and Post-Prandial Glucose Levels In Japanese Subjects With Type 2 Diabetes." Poster presented (abstract # 0520-P) at the 67th Scientific Sessions of the American Diabetes Association, Chicago, IL, June 23-26 2007.

2. Vilsboell T, Brock B, Perrild H, et al. 14 weeks of liraglutide therapy in subjects with T2DM significantly improves 1st phase insulin secretion and maximal beta-cell secretory capacity. Late-breaking oral presentation (abstract 750195) at: 66th annual meeting of the American Diabetes Association, Washington, DC, June 9-13, 2006.

3. Vilsboell T, Zdravkovic M, Le-Thi T, et al. Liraglutide significantly improves glycemic control, and lowers body weight without risk of either major or minor hypoglycemic episodes in subjects with type 2 diabetes. Oral presentation (abstract # 115-OR) at: 66th annual meeting of the American Diabetes Association, Washington, DC, June 9-13, 2006.'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:7/1/2015)... FRANCISCO , July 1, 2015  goBalto, ... startup solutions, announced today unprecedented growth in serving ... is intense pressure to speed clinical trials and ... globalization, and paper-based methods have stalled these efforts," ... current status of clinical trials has encouraged Industry ...
(Date:7/1/2015)... Prismic Pharmaceuticals, Inc., a specialty pharmaceutical company ... announced the election of Joseph J. Krivulka ... of Directors. Commenting on the election of ... Chairman and CEO of Prismic, stated, "We are delighted ... have accepted our invitation to join Prismic,s Board ...
(Date:7/1/2015)... DIEGO , July 1, 2015  Imprimis ... company focused on the development and commercialization of ... company will ring The Nasdaq stock market closing ... celebrating the growing success of its Go Dropless™ ... 3.6 million cataract procedures are performed annually in ...
Breaking Medicine Technology:goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... 14 Medizone International, Inc. (OTC Bulletin ... AsepticSure(TM) trials have begun at Innovation Park, Queen,s University. ... and second round of laboratory testing, this third round ... in order to obtain maximum bactericidal action in combination ...
... , TROY, Mich., Oct. 14 Somanetics Corporation (Nasdaq: ... an Exclusive Sublicense Agreement with Raba Equity Partners II, ... Somanetics has obtained exclusive rights, subject to specified rights ... Johns Hopkins University, to new cerebral autoregulation technology developed ...
Cached Medicine Technology:Medizone International Announces Third Round of AsepticSure 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 4Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5
(Date:7/2/2015)... Beach, FL (PRWEB) , ... July 02, 2015 , ... ... information and entertainment differently, but also how they interact with products in their everyday ... everything from appliances and security systems to home entertainment and safety, as well as ...
(Date:7/2/2015)... ... ... an effect on the body. And during the hot summer season, fitness guru Iryna Lobur ... of the right foods, as well as drinking plenty of water. , But on the ... front as well, with sweet treats like ice cream and snow cones more popular than ever ...
(Date:7/2/2015)... ... July 02, 2015 , ... Patton State Hospital ... State Hospitals. Prior to using Winscribe’s dictation and clinical documentation solutions, Patton State ... manage their organization’s dictation and transcription processes. , Over the years, ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... their products, services, channels and business models. To help manage the increasing demand ... addition of Mark Benkendorf as SVP of Strategic Engagements. , Benkendorf is a ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... sponsorship complete, St. Joseph’s Health, located in Syracuse, N.Y., is now a member ... we have gained an admirable and important partner committed to delivering high-value care, ...
Breaking Medicine News(10 mins):Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 3Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 4Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:St. Joseph’s Health Now a Member of Trinity Health 2Health News:St. Joseph’s Health Now a Member of Trinity Health 3Health News:St. Joseph’s Health Now a Member of Trinity Health 4
... be pleased with a new study suggesting music lessons help ... at the Chinese University of Hong Kong, indicates children with ... without training. ,Researchers put 135 boys between ages 6 ... had to recall words from a list and perform a ...
... study shows anemia may double the risk of an ... the ability to live independently. Researchers say seniors who ... just above the traditional cut-off point for the condition's ... than those who have normal blood hemoglobin levels.// ...
... of intraocular fluid into the venous system, wearing a ... to a report published in the August issue of ... that wearing a tight necktie produces a significant rise ... Although it could take several years of tie wearing ...
... make people more susceptible to depression after stressful events, such ... have to inherit one copy of the gene, from either ... Britain, New Zealand and the United States found. ,Stress events, ... of the five leading causes of disability in the world. ...
... exams can make you break out. There are a lot ... clinical studies have looked at this, Dr. Alexa B. Kimball, ... study with the goal of debunking this myth," she added. ... clearly that acne causes stress," Kimball noted. But when she ...
... claim eating pizza regularly reduced the risk of developing throat ... also fell by 26 percent and mouth cancer by 34 ... developed cancer of the mouth, esophagus, throat or colon and ... Those who ate pizza at least once a week had ...
Cached Medicine News:
... is winning the hearts of cardiologists and ... are the operative words for Heartline™. Patients ... time they and their attending physician know ... in their heart condition is only a ...
... Implant is 40% thinner than our ... thickness provides improved eyelid cosmesis while ... proven Contour implant. Our ThinProfile ... curvature and precise tapering to produce ...
... IOPac give you corrected IOP measurements in the ... importance of CCT. Make your IOP readings ... glaucoma pachymeter with built-in IOP calculations. ... professional, it provides accurate corneal measurements in a ...
Use the Oculus Mesotest II before and after IOL or refractive surgery. Selectable Landolt ring positions. Accurate measurements in four contrast levels, with and without glare, independent of the pup...
Medicine Products: